Logo
LLY logo
Eli Lilly and Company
LLY
802.83 (-2.02%) 16.22
720.73(B)
Health Care
Pharmaceuticals
Eli Lilly and Company discovers develops and markets human pharmaceuticals in the United States Europe China Japan and internationally. The company offers Basaglar Humalog Humalog Mix 75/25 Humalog U-100 Humalog U-200 Humalog Mix 50/50 insulin lispro insulin lispro protamine insulin lispro mix 75/25 Humulin Humulin 70/30 Humulin N Humulin R and Humulin U-500 for diabetes; Jardiance Mounjaro and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products including Alimta Cyramza Erbitux Jaypirca Retevmo Tyvyt and Verzenio. In addition the company offers Olumiant for rheumatoid arthritis atopic dermatitis severe alopecia areata and COVID-19; Taltz for plaque psoriasis psoriatic arthritis ankylosing spondylitis and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder diabetic peripheral neuropathic pain generalized anxiety disorder fibromyalgia and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals Inc.; F. Hoffmann-La Roche Ltd and Genentech Inc.; Biologics Inc. AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co. Ltd as well as Strategic Collaboration with Eli Lilly to advance development of its myeloid engager platform for autoimmune disease. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis Indiana.

My Quality Checklist

5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Past Net Income CAGR > 0%
Est. EPS Growth > 5%
0.0%of Portfolio

My holdings

Day change:
Total change:
Shares:
Cost basis:
Compare
Market cap:$720.73(B)
EV:$756.82(B)
Total Equity:$18.35(B)
Div. yield:0.70%
Earnings date:Oct-30-2025
P/E:52.34
P/E (fwd):35.17
P/FCF:147.31
P/S:13.56
P/B:39.41
EPS:$15.3
EPS (fwd):$22.8
FCF/share:$5.5
Book value/share:$20.4
Dividend/share:$5.6
ROIC:27.3%
ROA:16.0%
ROE:86.7%
Gross margin:82.6%
Net margin:25.9%
Valuation Summary TTM Financials Growth Estimates Historical Data KPIs Competitors & Peers Ownership Tools

LLY Valuation & Price Targets

Current Price
$803
Day change: -2.02%
PEvaluation
N/A
N/A
Analyst targets
N/A
N/A
DCF (2-stage)
N/A
N/A
DCF (simple)
N/A
N/A
DCF (exit mult.)
N/A
N/A
EPS growth
N/A
N/A
Revenue growth
N/A
N/A
Peter Lynch FV
N/A
N/A
Graham No.
N/A
N/A
DDM
N/A
N/A

PEvaluation

13% overvalued
Low
$522
Mid
$695
High
$869
Current price
$803
Fair P/E
Margin of safety
EPS
Market Model
Shares outstan...ROICRevenue growthDebt/FCFAssets/Liabili...
Economic moat: Very wide

EPS Estimates

LowAvgHigh#
FY+121.922.825.026
FY+226.230.435.727
FY+331.637.143.622
FY+434.542.748.213
FY+536.048.154.613

Analyst Price Targets

9% undervalued
Low
$650
Mid
$875
High
$1190
Current price
$803

Analyst Recommendations

Strong Buy3
Buy16
Hold8
Sell0
Strong Sell1

2-stage DCF

First Stage Duration
Starting Free Cash Flow
First Stage Growth Rate
LowMidHigh
Terminal Growth Rate
LowMidHigh
Discount Rate

Discounted Cash Flow

Forecast years
Terminal Growth Rate
LowMidHigh
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

Discounted Cash Flow (exit mult.)

Forecast years
Exit FCF Multiple
LowMidHigh
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

EPS Growth

Forecast years
Starting EPS
EPS Growth Rate
LowMidHigh
Final P/E
LowMidHigh
Discount Rate

Revenue Growth Valuation

Forecast Years
Base Revenue
Revenue Growth Rate
LowMidHigh
Final Net Margin
LowMidHigh
Final P/E Ratio
LowMidHigh
Discount Rate

Peter Lynch Fair Value

Earnings Per Share
Growth Rate

Graham Formula

Earnings Per Share
EPS Growth (7-10 years)
Government Bond Rate

Dividend Discount Model

Annual Dividend
First Stage Length (Years)
First Stage Growth Rate
Final Growth Rate
Discount Rate

TTM Financials

Income (TTM)

RevenueGrossNet
Revenue$53.26(B)
Gross profit$44.01(B)
EBITDA$24.78(B)
Net income$13.80(B)
Gross margin82.6%
Operating margin42.8%
Net margin25.9%
Shares outstanding:897.74(M)

Balance sheet

Cash & ST inv.Other ST assetsLong term assetsCurrent liabilitiesLong term debtOther LT liabilitiesEquity
Total assets$100.92(B)
Current assets$49.85(B)
Total liabilities$82.57(B)
Current liabilities$39.02(B)
Cash & Short-term inv.$3.55(B)
Long-term debt$34.26(B)
Total intangibles$11.68(B)
PP&E$20.53(B)

Cash flow (TTM)

CFOCFICFF
FCF$4.88(B)
CapEx$-6.05(B)
Dividends paid$-5.03(B)
Stock issued$0
Stock repurchased$-4.39(B)
Stock-based comp.$613.90(M)
Debt issued$11.43(B)
Debt repaid$-1.07(B)

Per share data (TTM)

Price: $803
Revenue: $59.2 (13.6x | 7.4%) Gross profit: $49.0 (16.4x | 6.1%) Earnings: $15.3 (52.3x | 1.9%)
FCF: $5.45 (147.3x | 0.7%) Stock-based Comp.: $0.68 (1174.0x | 0.1%) CapEx.: $6.74 (119.1x | 0.8%) Dividend: $5.60 (143.4x | 0.7%)
Total Assets: $112 (7.1x | 14.0%) Total Liabilities: $92.0 (8.7x | 11.5%) Book Value: $20.4 (39.4x | 2.5%) Cash & ST inv.: $3.95 (203.3x | 0.5%) Debt: $38.2 (21.0x | 4.8%)
Earnings FY+1: $22.8 (35.2x | 2.8%) Earnings FY+2: $30.4 (26.4x | 3.8%) Earnings FY+3: $37.1 (21.6x | 4.6%) Earnings FY+4: $42.7 (18.8x | 5.3%) Earnings FY+5: $48.1 (16.7x | 6.0%)
FCF FY+1: $14.4 (55.9x | 1.8%) FCF FY+2: $17.3 (46.5x | 2.2%) FCF FY+3: $26.5 (30.2x | 3.3%) FCF FY+4: $30.5 (26.3x | 3.8%) FCF FY+5: $38.9 (20.6x | 4.9%)

Growth Estimates

Revenue

CAGR: 13.4%
FY+1FY+2FY+3FY+4FY+5
FY+1$61.70(B)
FY+2(+18.7%)$73.27(B)
FY+3(+15.6%)$84.72(B)
FY+4(+10.2%)$93.36(B)
FY+5(+9.1%)$101.86(B)

Net Income

CAGR: 19.7%
FY+1FY+2FY+3FY+4FY+5
FY+1$20.57(B)
FY+2(+32.5%)$27.25(B)
FY+3(+21.4%)$33.09(B)
FY+4(+13.7%)$37.63(B)
FY+5(+12.4%)$42.28(B)

EPS

CAGR: 20.5%
FY+1FY+2FY+3FY+4FY+5
FY+1$22.83
FY+2(+33.0%)$30.36
FY+3(+22.3%)$37.12
FY+4(+15.1%)$42.72
FY+5(+12.7%)$48.15

FCF per share

CAGR: 28.3%
FY+1FY+2FY+3FY+4FY+5
FY+1$14.36
FY+2(+20.2%)$17.27
FY+3(+53.7%)$26.54
FY+4(+14.9%)$30.50
FY+5(+27.7%)$38.94

Historical Financials

Showing limited histrical data.
TTM (Y)TTM (Q)FYFQ
Income(show more...)
Q2'20 (TTM)Q2'21 (TTM)Q2'22 (TTM)Q2'23 (TTM)Q2'24 (TTM)Q2'25 (TTM)0.010.0(B)20.0(B)30.0(B)40.0(B)50.0(B)
Revenue Operating Income Net IncomeCOGSGross ProfitTotal OpEx.R&DSG&AInterest ExpenseInterest IncomePre-tax incomeIncome tax
Cash flow(show more...)
Q2'20 (TTM)Q2'21 (TTM)Q2'22 (TTM)Q2'23 (TTM)Q2'24 (TTM)Q2'25 (TTM)0.01.0(B)2.0(B)3.0(B)4.0(B)5.0(B)6.0(B)
Stock-based Comp. FCFCFONet IncomeD&ACFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet(show more...)
Q2'20 (TTM)Q2'21 (TTM)Q2'22 (TTM)Q2'23 (TTM)Q2'24 (TTM)Q2'25 (TTM)0.020.0(B)40.0(B)60.0(B)80.0(B)100.0(B)
Total Assets Total LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EIntangible AssetsGoodwillCurrent liabilitiesShort-Term DebtAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Per share data(show more...)
Q2'20 (TTM)Q2'21 (TTM)Q2'22 (TTM)Q2'23 (TTM)Q2'24 (TTM)Q2'25 (TTM)0.02.04.06.08.010.012.014.0
EPS (Basic) FCF/Share Dividend/ShareEPS (Diluted)Book value/ShareCash & ST inv./ShareDebt/Share
Ratios(show more...)
Q2'20 (TTM)Q2'21 (TTM)Q2'22 (TTM)Q2'23 (TTM)Q2'24 (TTM)Q2'25 (TTM)0.020.040.060.080.0100.0
P/E P/S EV/EarningsP/FCFP/BEV/FCFDebt/EquityPayout ratio
Margins(show more...)
Q2'20 (TTM)Q2'21 (TTM)Q2'22 (TTM)Q2'23 (TTM)Q2'24 (TTM)Q2'25 (TTM)0%20%40%60%80%
Net Income Margin Operating Margin Gross MarginEBITDA MarginFCF Margin
Returns(show more...)
Q2'20 (TTM)Q2'21 (TTM)Q2'22 (TTM)Q2'23 (TTM)Q2'24 (TTM)Q2'25 (TTM)0%5%10%15%20%25%30%35%
ROIC ROAROCEROE
Shares outstanding(show more...)
Q2'20 (TTM)Q2'21 (TTM)Q2'22 (TTM)Q2'23 (TTM)Q2'24 (TTM)Q2'25 (TTM)0.0200.0(M)400.0(M)600.0(M)800.0(M)
Shares (Basic)Shares (Diluted)
Market Cap.(show more...)
Q2'20 (TTM)Q2'21 (TTM)Q2'22 (TTM)Q2'23 (TTM)Q2'24 (TTM)Q2'25 (TTM)0.0200.0(B)400.0(B)600.0(B)800.0(B)
Market Cap.

KPIs

Revenue By Geography(show more...)
12/20223/20236/20239/202312/20233/20246/20249/202412/20243/2025
Rest of World US Europe China Japan
Revenue By Segment(show more...)
12/20223/20236/20239/202312/20233/20246/20249/202412/20243/2025
Neuroscience Immunology Cardiovascular Oncology Animal Health Diabetes Other

Competitors & Peers

Ownership

Major holders

*Excludes indirect insider ownership

Insiders: 0.16%
Institutions: 83.84%
Other: 16.00%

Institutional ownership

10.14% Lilly Endowment, Inc8.50% Vanguard Group Inc6.97% Blackrock Inc.5.42% PNC Financial Services...3.65% State Street Corporati...2.71% FMR, LLC2.19% Capital Research Globa...1.92% Geode Capital Manageme...1.86% Capital World Investor...1.78% Price (T.Rowe) Associa...38.70% Others

Trading Summary

In the past year, insiders have bought $4.54(M) worth of the company's stock, and sold $1.12(B).

Congress members have bought between $87010 - $305000 worth of the company's stock, and sold between $114023 - $535000.

Insider transactions

$0.002025-11$0.00
$0.002025-10$0.00
$99.59(M)2025-09$0.00
$1.52(M)2025-08$4.54(M)
$225.42(M)2025-07$0.00
$0.002025-06$0.00
$1.65(M)2025-05$0.00
$0.002025-04$0.00
$205.14(M)2025-03$0.00
$585.13(M)2025-02$0.00
$0.002025-01$0.00
$0.002024-12$0.00
$7230422024-11$0.00
DateSharesTotal ($)Price ($)NameTitle
Sell2025-09-1923,66518,058,643763.1LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Sell2025-09-18106,62681,531,959764.7LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Grant2025-09-1564,958826.3SULZBERGER GABRIELLEDirector
Grant2025-09-15139,917762.8FYRWALD J. ERIKDirector
Grant2025-09-15139,917762.8HEDLEY MARY LYNNEDirector
Grant2025-09-151914,834780.7LUCIANO JUAN RDirector
Grant2025-09-151511,750783.3ALVAREZ RALPHDirector
Grant2025-09-051700.0HERNANDEZ EDGARDOOfficer
Sell2025-08-281,000734,930734.9ZAKROWSKI DONALD AOfficer
Grant2025-08-1874,958708.3SULZBERGER GABRIELLEDirector
Grant2025-08-18149,916708.3FYRWALD J. ERIKDirector
Grant2025-08-18149,916708.3HEDLEY MARY LYNNEDirector
Grant2025-08-182114,834706.4LUCIANO JUAN RDirector
Grant2025-08-181611,750734.4ALVAREZ RALPHDirector
Buy2025-08-15715494,627691.8MONTARCE LUCAS EChief Financial Officer
Buy2025-08-13758500,473660.3ALVAREZ RALPHDirector
Buy2025-08-131,000647,360647.4VAN NAARDEN JACOB S.Officer
Buy2025-08-121,5651,005,242642.3FYRWALD J. ERIKDirector
Buy2025-08-121,6321,052,263644.8RICKS DAVID AChief Executive Officer
Buy2025-08-121,000634,405634.4SKOVRONSKY DANIELOfficer
Buy2025-08-1211775,018641.2SULZBERGER GABRIELLEDirector
Sell2025-08-111,250783,762627.0YUFFA ILYAOfficer
Buy2025-08-08200127,913639.6JACKSON JAMEREDirector
Sell2025-07-24280,000225,419,259805.1LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Grant2025-07-2164,958826.3SULZBERGER GABRIELLEDirector
Grant2025-07-21139,917762.8FYRWALD J. ERIKDirector
Grant2025-07-21139,917762.8HEDLEY MARY LYNNEDirector
Grant2025-07-211914,834780.7LUCIANO JUAN RDirector
Grant2025-07-211511,750783.3ALVAREZ RALPHDirector
Grant2025-06-1664,959826.5SULZBERGER GABRIELLEDirector
Grant2025-06-161814,834824.1LUCIANO JUAN RDirector
Grant2025-06-16129,916826.3FYRWALD J. ERIKDirector
Grant2025-06-16129,916826.3HEDLEY MARY LYNNEDirector
Grant2025-06-161411,750839.3ALVAREZ RALPHDirector
Sell2025-05-271,000716,410716.4ZAKROWSKI DONALD AOfficer
Grant2025-05-1964,958826.3SULZBERGER GABRIELLEDirector
Grant2025-05-19139,917762.8FYRWALD J. ERIKDirector
Grant2025-05-19139,917762.8HEDLEY MARY LYNNEDirector
Grant2025-05-191914,833780.7LUCIANO JUAN RDirector
Grant2025-05-191511,750783.3ALVAREZ RALPHDirector
Sell2025-05-141,250936,550749.2YUFFA ILYAOfficer
Grant2025-05-0217,87500.0HAKIM ANATGeneral Counsel
Grant2025-04-2164,958826.3SULZBERGER GABRIELLEDirector
Grant2025-04-21129,917826.4FYRWALD J. ERIKDirector
Grant2025-04-21129,917826.4HEDLEY MARY LYNNEDirector
Grant2025-04-211814,833824.1LUCIANO JUAN RDirector
Grant2025-04-211411,750839.3ALVAREZ RALPHDirector
Grant2025-03-1764,958826.3SULZBERGER GABRIELLEDirector
Grant2025-03-17129,917826.4FYRWALD J. ERIKDirector
Grant2025-03-17129,917826.4HEDLEY MARY LYNNEDirector
Grant2025-03-171714,833872.5LUCIANO JUAN RDirector
Grant2025-03-171411,750839.3ALVAREZ RALPHDirector
Sell2025-03-131,000818,240818.2ZAKROWSKI DONALD AOfficer
Sell2025-03-03220,000204,326,151928.8LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Sell2025-02-25225,000203,190,794903.1LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Sell2025-02-2460,43253,425,407884.1LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Sell2025-02-2199,45287,786,505882.7LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Sell2025-02-2014,68512,893,353878.0LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Grant2025-02-2046000.0DOZIER ERICOfficer
Sell2025-02-199,9858,771,285878.4LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Grant2025-02-1854,958991.6SULZBERGER GABRIELLEDirector
Grant2025-02-18119,917901.5FYRWALD J. ERIKDirector
Grant2025-02-18119,917901.5HEDLEY MARY LYNNEDirector
Grant2025-02-181714,833872.5LUCIANO JUAN RDirector
Grant2025-02-181311,750903.8ALVAREZ RALPHDirector
Sell2025-02-1335,44631,175,396879.5LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Sell2025-02-105,0004,316,065863.2SKOVRONSKY DANIELOfficer
Grant2025-02-107,1236,189,335868.9YUFFA ILYAOfficer
Grant2025-02-105,9745,190,812868.9HERNANDEZ EDGARDOOfficer
Grant2025-02-106,8155,921,593868.9RAU DIOGOChief Technology Officer
Grant2025-02-10919798,957869.4DOZIER ERICOfficer
Grant2025-02-1055,13147,902,710868.9RICKS DAVID AChief Executive Officer
Grant2025-02-101,3591,181,381869.3ZAKROWSKI DONALD AOfficer
Grant2025-02-107,1706,230,302868.9JONSSON PATRIKOfficer
Grant2025-02-106,1035,303,491869.0VAN NAARDEN JACOB S.Officer
Grant2025-02-1010,3208,967,672869.0HAKIM ANATGeneral Counsel
Grant2025-02-1018,77116,310,400868.9SKOVRONSKY DANIELOfficer
Grant2025-02-106,8285,933,469869.0WHITE ANNE EPresident
Grant2025-02-102,8952,516,217869.2MONTARCE LUCAS EChief Financial Officer
Sell2025-02-06210,000183,567,262874.1LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of Security
Grant2025-01-2164,958826.3SULZBERGER GABRIELLEDirector
Grant2025-01-21139,916762.8FYRWALD J. ERIKDirector
Grant2025-01-21139,916762.8HEDLEY MARY LYNNEDirector
Grant2025-01-211914,834780.7LUCIANO JUAN RDirector
Grant2025-01-211511,750783.3ALVAREZ RALPHDirector
Grant2024-12-16129,917826.4SULZBERGER GABRIELLEDirector
Grant2024-12-161914,834780.7LUCIANO JUAN RDirector
Grant2024-12-16129,917826.4HEDLEY MARY LYNNEDirector
Grant2024-12-16129,667805.6JOHNSON KIMBERLY HDirector
Grant2024-12-161511,750783.3ALVAREZ RALPHDirector
Grant2024-11-18316229,917727.6SULZBERGER GABRIELLEDirector
Grant2024-11-18322234,833729.3LUCIANO JUAN RDirector
Grant2024-11-18320233,089728.4FYRWALD J. ERIKDirector
Grant2024-11-18316229,917727.6HEDLEY MARY LYNNEDirector
Grant2024-11-18302220,000728.5BAICKER KATHERINEDirector
Grant2024-11-18315229,666729.1JOHNSON KIMBERLY HDirector
Grant2024-11-18302220,000728.5WALKER KAREN SAMMISDirector
Grant2024-11-18302220,000728.5KAELIN WILLIAM G JRDirector
Grant2024-11-18302220,000728.5JACKSON JAMEREDirector
Grant2024-11-18318231,750728.8ALVAREZ RALPHDirector
Sell2024-11-08900723,042803.4ZAKROWSKI DONALD AOfficer
Grant2024-10-314,30200.0VAN NAARDEN JACOB S.Officer
Grant2024-10-21119,967906.1SULZBERGER GABRIELLEDirector
Grant2024-10-211614,498906.1LUCIANO JUAN RDirector
Grant2024-10-21119,967906.1HEDLEY MARY LYNNEDirector
Grant2024-10-21119,967906.1JOHNSON KIMBERLY HDirector
Grant2024-10-211311,780906.2ALVAREZ RALPHDirector

Congressional trading

$0.002025-11$0.00
$0.002025-10$0.00
$0.002025-09$0.00
$0.002025-08$0.00
$0.002025-07$0.00
$325012025-06$8001
$160012025-05$24002
$645032025-04$32501
$80012025-03$8001
$830012025-02$0.00
$80012025-01$83001
$560042024-12$8001
$485022024-11$0.00
DatePoliticianPartyChamberAmount ($)
Buy2025-06-06Ro KhannaDHouse$1,001 - $15,000
Sell2025-06-03Jonathan L. JacksonDHouse$15,001 - $50,000
Sell2025-05-30Gilbert Ray Cisneros, Jr.DHouse$1,001 - $15,000
Buy2025-05-14Marjorie Taylor GreeneRHouse$1,001 - $15,000
Sell2025-05-13Josh GottheimerDHouse$1,001 - $15,000
Buy2025-05-05Marjorie Taylor GreeneRHouse$1,001 - $15,000
Buy2025-05-01Josh GottheimerDHouse$1,001 - $15,000
Buy2025-04-21Jonathan L. JacksonDHouse$15,001 - $50,000
Sell2025-04-21Bruce WestermanRHouse$1,001 - $15,000
Sell2025-04-15Tommy TubervilleRSenate$15,001 - $50,000
Sell2025-04-09Josh GottheimerDHouse$1,001 - $15,000
Sell2025-04-08Rob BresnahanRHouse$1,001 - $15,000
Sell2025-04-07Julie JohnsonDHouse$1,001 - $15,000
Sell2025-03-10Josh GottheimerDHouse$1,001 - $15,000
Buy2025-03-03Bruce WestermanRHouse$1,001 - $15,000
Sell2025-02-19Josh GottheimerDHouse$1,001 - $15,000
Sell2025-02-10Ron WydenDSenate$50,001 - $100,000
Buy2025-01-22Ron WydenDSenate$50,001 - $100,000
Buy2025-01-21Marjorie Taylor GreeneRHouse$1,001 - $15,000
Sell2025-01-08Josh GottheimerDHouse$1,001 - $15,000
Buy2024-12-24Marjorie Taylor GreeneRHouse$1,001 - $15,000
Sell2024-12-18Josh GottheimerDHouse$1,001 - $15,000
Sell2024-12-16Josh GottheimerDHouse$1,001 - $15,000
Sell2024-12-13Josh GottheimerDHouse$1,001 - $15,000
Sell2024-12-12Josh GottheimerDHouse$1,001 - $15,000
Sell2024-12-11Josh GottheimerDHouse$1,001 - $15,000
Sell2024-12-10Josh GottheimerDHouse$1,001 - $15,000
Sell2024-12-09Josh GottheimerDHouse$1,001 - $15,000
Sell2024-11-19Josh GottheimerDHouse$1,001 - $15,000
Sell2024-11-14Josh GottheimerDHouse$1,001 - $15,000
Sell2024-11-08Greg LandsmanDHouse$15,001 - $50,000
Buy2024-10-30Sheldon WhitehouseDSenate$15,001 - $50,000
Sell2024-10-16Josh GottheimerDHouse$1,001 - $15,000

Summary

Tools

Dividend Income

Investment Amount
Dividend Yield
What is the Dividend Income Calculator?

The Dividend Income Calculator helps you estimate the yearly, quarterly, monthly, and daily income of your investments.

How to Use This Calculator?

Enter the dividend yield and the invested amount. Optionally, preload stock data to automatically fetch the dividend yield.

Required Investment

Dividend Yield
Desired Yearly Payout
Desired Quarterly Payout
Desired Monthly Payout
What is the Required Investment Calculator?

The Required Investment Calculator helps you determine the amount of money you need to invest in a stock to achieve a desired dividend.

How to Use This Calculator?

Enter the dividend yield and your desired dividend income. Optionally, preload stock data to automatically fetch the dividend yield.

Future Dividend Yield

Base Dividend
Current Price
Number of Years
Dividend Growth Rate
What is the Future Yield Calculator?

The Future Yield Calculator helps you estimate the future dividend yield of a stock based on its current dividend, price, and expected dividend growth rate.

How to Use This Calculator?

Enter the base dividend, current price, number of years, and dividend growth rate. Optionally, preload stock data to automatically fetch the dividend and price. The calculator will display the current yield and the projected future yield.

Future Dividend Income

Base Dividend
Number of Years
Dividend Growth Rate
What is the Future Dividend Income Calculator?

The Future Dividend Income Calculator helps you estimate the future dividend income from your investments based on the current dividend yield and expected growth rate.

How to Use This Calculator?

Enter the current dividend yield, expected growth rate, and investment duration. Optionally, preload stock data to automatically fetch the dividend yield.

(C) PEVALUATOR
About
Terms & privacy
Price charts & news courtesy of TradingView
Blog
Contact